Cleared Traditional

K043490 - PD-IO DISPOSABLE INTRAOSSEOUS INFUSION ...

K043490 is an FDA 510(k) clearance for PD-IO DISPOSABLE INTRAOSSEOUS INFUSION ..., manufactured by Vidacare Corporation. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 63-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2005
Decision
63d
Days
Class 2
Risk

K043490 is an FDA 510(k) clearance for the PD-IO DISPOSABLE INTRAOSSEOUS INFUSION NEEDLE. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Vidacare Corporation (Irvine, US). The FDA issued a Cleared decision on February 18, 2005 after a review of 63 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vidacare Corporation devices

FDA 510(k) Submission Details - K043490

510(k) Number K043490 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 17, 2004
Decision Date February 18, 2005
Days to Decision 63 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 129d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 264
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K043490.
BD AUTOSHIELD PEN NEEDLE
K060007 · Becton, Dickinson & CO · Mar 2006
NIPRO HYPODERMIC NEEDLE
K052474 · Nipro Medical Corp. · Nov 2005
BD PEN NEEDLE
K051899 · Becton, Dickinson & CO · Sep 2005
MODIFICATION TO BD ECLIPSE HYPODERMIC NEEDLE
K043397 · Becton, Dickinson & CO · Dec 2004
VASCULAR SOLUTIONS SCLERO-KIT
K043019 · Vascular Solutions, Inc. · Dec 2004
HYPODERMIC NEEDLE-PRO EDGE NEEDLE PROTECTION DEVICE
K041399 · Smiths Medical Asd, Inc. · Jul 2004